Autoimmune disease and risk for Parkinson disease
- 3 November 2009
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 73 (18), 1462-1468
- https://doi.org/10.1212/wnl.0b013e3181c06635
Abstract
Inflammatory mediators are increased in autoimmune diseases and may activate microglia and might cause an inflammatory state and degeneration of dopaminergic neurons in the brain. Thus, we evaluated whether having an autoimmune disease increases the risk for developing Parkinson disease (PD). A population based case-control study was conducted in Denmark of 13,695 patients with a primary diagnosis of PD recorded in the Danish National Hospital Register during the period 1986-2006. Each case was matched on year of birth and sex to 5 population controls selected at random from among inhabitants of Denmark who were alive at the date of the patient's diagnosis. The main exposure measure was a hospital diagnosis of 1 of 32 selected autoimmune diseases recorded 5 or more years before the index date in the files of the Danish Hospital Register. We observed no overall association between a diagnosis of autoimmune disease and risk for subsequent PD (odds ratio 0.96, 95% confidence interval 0.85-1.08). In a subgroup of patients with autoimmune diseases with systemic involvement, primarily rheumatoid arthritis, we saw a decrease in risk for PD of 30%. Our results do not support the hypothesis that autoimmune diseases increase the risk for Parkinson disease. The decreased risk observed among patients with rheumatoid arthritis might be explained by underdiagnosis of movement disorders such as Parkinson disease in this patient group or by a protective effect of the treatment with anti-inflammatory drugs over prolonged periods.Keywords
This publication has 28 references indexed in Scilit:
- Risk of Parkinson's disease after hospital contact for head injury: population based case-control studyBMJ, 2008
- The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative diseaseBrain, Behavior, and Immunity, 2004
- Nonsteroidal Anti-inflammatory Drugs and the Risk of Parkinson DiseaseArchives of Neurology, 2003
- Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegenerationProceedings of the National Academy of Sciences of the United States of America, 2003
- Juvenile parkinsonism as a manifestation of systemic lupus erythematosus: Case report and review of the literatureMovement Disorders, 2002
- Association between Early-Onset Parkinson's Disease and Mutations in theParkinGeneThe New England Journal of Medicine, 2000
- Antidopaminergic antibodies in a patient with a complex autoimmune disorder and rapidly progressing Parkinson's diseaseJournal of Allergy and Clinical Immunology, 1995
- Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patientsNeuroscience Letters, 1994
- Tumor necrosis factor-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patientsNeuroscience Letters, 1994
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987